Its just the drug pigment, not blood and absolutely safe
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760

Our diagnostic workup typically includes: Heavy metal testing to identify toxic metal burden from mercury, lead, arsenic, and cadmium Comprehensive hormone panel (DUTCH test) to evaluate thyroid function, cortisol rhythm, DHEA, testosterone, and estrogen metabolism Nutrient testing to check for deficiencies in iron, ferritin, zinc, biotin, and vitamin D all essential for healthy hair cycling Inflammatory markers to assess systemic inflammation that may be damaging follicles Once we understand the full picture, we build a personalized protocol
Earn 5x Health & Beautycard Points Earn 5x points on every Weight Loss Consultation and treat yourself to your favourite Superdrug products in-store or online
Koufoglou, E., Kourlaba, G., & Michos, A
Until stereoisomer-specific studies and formal pharmacovigilance data are available, any long-term or high-dose use carries unknown risk